Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal
Selma Ugurel

Showing results (41-50 of 489) with videos related to

Pageof 49
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
JAAD Case Reports|January 21, 2025
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanomaAlpaslan Tasdogan, Dirk Schadendorf, Selma Ugurel
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 17, 2003
Chemosensitivity testing in malignant melanomaSelma Ugurel, Wolfgang Tilgen, Uwe Reinhold
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Cutaneous adverse events to systemic anticancer therapies : Hand-foot syndrome and nail changes]Selma Ugurel, Claudia Pföhler, Ralf Gutzmer
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 14, 2009
[Slowly changing nodules on both lower limbs in a 54-year old patient]Hermann Kneitz, Eva-B Bröcker, Selma Ugurel
The New England Journal of Medicine|October 3, 2006
Molecular mechanisms in melanomaSelma Ugurel, Roland Houben, Jürgen C Becker
Current Opinion in Oncology|January 12, 2012
Merkel cell carcinoma: recent insights and new treatment optionsDavid Schrama, Selma Ugurel, Jürgen C Becker
The Journal of Investigative Dermatology|January 16, 2013
Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agentSelma Ugurel, Annette Paschen, Jürgen C Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2008
Strategies to optimize the use of targeted agents for tumor therapyJürgen C Becker, Selma Ugurel, David Schrama
Pageof 49

Showing results (41-50 of 489) with videos related to

Sort By:
Pageof 49
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 31, 2022
S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)Doris Helbig, Mirjana Ziemer, Edgar Dippel, et al.
JAAD Case Reports|January 21, 2025
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanomaAlpaslan Tasdogan, Dirk Schadendorf, Selma Ugurel
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 17, 2003
Chemosensitivity testing in malignant melanomaSelma Ugurel, Wolfgang Tilgen, Uwe Reinhold
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Cutaneous adverse events to systemic anticancer therapies : Hand-foot syndrome and nail changes]Selma Ugurel, Claudia Pföhler, Ralf Gutzmer
European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 14, 2009
[Slowly changing nodules on both lower limbs in a 54-year old patient]Hermann Kneitz, Eva-B Bröcker, Selma Ugurel
The New England Journal of Medicine|October 3, 2006
Molecular mechanisms in melanomaSelma Ugurel, Roland Houben, Jürgen C Becker
Current Opinion in Oncology|January 12, 2012
Merkel cell carcinoma: recent insights and new treatment optionsDavid Schrama, Selma Ugurel, Jürgen C Becker
The Journal of Investigative Dermatology|January 16, 2013
Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agentSelma Ugurel, Annette Paschen, Jürgen C Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2008
Strategies to optimize the use of targeted agents for tumor therapyJürgen C Becker, Selma Ugurel, David Schrama
Pageof 49